Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

I Aspirin

Stella L, Donati MB, Gaetano G (1975) Bleeding time in laboratory animals. I. Aspirin does not prolong bleeding time in rats. Thromb Res 7 709-716... [Pg.300]

In four subjects given a single oral dose of aspirin 37.5 mg before and after a natural stable fish oil daily for 1 week, serum thromboxane A2 fell by 40% after aspirin alone, but by 62% after fish oil -I- aspirin, and leukotriene B4 rose by 19% after aspirin and fell by 69% after fish oil -1- aspirin serum prostacyclin fell equally in both cases (15). [Pg.1365]

Propoxyphene (Darvon) Propoxyphene Acetaminophen (Darvocef) Propoxyphene Aspirin (Darvon Compound-65/ Darvon-N -i- Aspirin) [C-IV] [Narcoric Analgesic]... [Pg.266]

ASPIRIN IMMUNOMODULATING DRUGS- CORTICOSTEROIDS Corticosteroids i aspirin levels, and therefore there is a risk of salicylate toxicity when withdrawing corticosteroids. Risk of gastric ulceration when aspirin is coadministered with corticosteroids Uncertain Watch for features of salicylate toxicity when withdrawing corticosteroids. Use aspirin in the lowest dose. Remember that corticosteroids may mask the features of peptic ulceration... [Pg.131]

The interaction between indometacin and ACE inhibitors is well established, with several studies showing that indometacin can reduce the blood pressure-lowering effect ofa number of ACE inhibitors. The interaction may not occur in all patients. If indometacin is required in a patient taking any ACE inhibitor, it would be prudent to monitor blood pressure. In a few small comparative studies, indometacin has been shown to have less effect on the calcium-channel blockers amlodipine, felodipine, and nifedipine, than on enalapril. See also, Calcium-channel blockers -i-Aspirin or NSAIDs , p.861. Therefore, a calcium-channel blocker may sometimes be an alternative to an ACE inhibitor in a patient requiring indometacin. [Pg.30]

Reactions of Aspirin, (i) Distinction from Salicylic acid. Shake up with water in two clean test-tubes a few crystals of a) salicylic acid, (0) aspirin, a very dilute aqueous solution of each substance being thus obtained. Note that the addition of i drop of ferric chloride solution to (a) gives an immediate purple coloration, due to the free —OH group, whereas (b) gives no coloration if the aspirin is pure. [Pg.111]

Hydrolysis of Aspirin. Gently boil a mixture of i g. of aspirin and 15 ml. of 10% sodium hydroxide solution in a 50 ml. conical flask under reflux for 20 minutes. Then cool the solution thoroughly and add dilute sulphuric acid until the precipitation of the... [Pg.111]

Acetylation. Boil i g. of salicylic acid with 4 ml. of an acetic anhydride-acetic acid mixture (equal volumes) under reflux for 10 minutes. Pour into water. Filter off the aspirin (p. 111), wash with water and recrystallise from aqueous acetic acid (1 1) m.p. l36 ... [Pg.352]

In the Direct SCF method, we do. not store the two-electron integrals over the basis functions, we recalculate them on demand every cycle of the HF procedure At first sight, this may seem wasteful, but Conventional methods rely on disk input/output transfer rates whilst Direct methods rely on processor power. There is obviously a balance between processor speed and disk I/O. Just for the record my calculation on aspirin (73 basis functions) took 363 s using the Direct method and 567 s using the Conventional method. [Pg.180]

I can explain a two-level hybrid calculation by referring to Figure 15.1, where I divide the system into two parts, the solute (aspirin) and the solvent (water). I... [Pg.261]

The popularity of aspirin has led to the preparation of a liost of relatively simple derivatives in the hope of finding a ilrug that would be either superior in action or better tolerated. i alicylamide (5), for example, is sometimes prescribed for pa-I Lents allergic to aspirin. It should be noted, however, that I his agent is not as active as the parent compound as an antiinflammatory or analgesic agent. This may be related to the fact I hat salicylamide does not undergo conversion to salicylic acid i 11 the body. [Pg.109]

The most common NSAID is aspirin, or acctylsalicvlic acid, whose use goes back to the late 1800s. It had been known from before the time of Hippocrates in 400 bc that fevers could be lowered by chewing the bark of willow trees. The active agent in willow bark was found in 1827 to be an aromatic compound called salicin, which could be converted by reaction with water into sal- icy I alcohol and then oxidized to give salicylic acid. Salicylic acid... [Pg.537]

Procedure. Inject 1 fiL of the sample solution and obtain a chromatogram. Under the above conditions the compounds are separated in about 3 minutes, the elution sequence being (1) aspirin (2) phenacetin (3) caffeine. Measure peak areas with an integrator and normalise the peak area for each compound (i.e. express each peak area as a percentage of the total peak area). Compare these results with the known composition of the mixture discrepancies arise because of different detector response to the same amount of each substance. [Pg.233]

There are few definitive data to substantiate the efficacy of LTRA therapy in refractory asthma, except for patients with aspirin-sensitive asthma. This is a fairly uncommon form of asthma that occurs generally in adults who often have no prior (i.e., childhood) history of asthma or atopy, may have nasal polyposis, and who often are dependent upon oral corticosteroids for control of their asthma. This syndrome is not specific to aspirin but is provoked by any inhibitors of the cycloxygenase-1 (COX-1) pathway. These patients have been shown to have a genetic defect that causes... [Pg.688]

Gamboa P. Sanz ML. Caballero MR. Urrutia I. 43 Antepara I. Esparza R. De Week L The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal and anti-inflam- 44 matory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin dS Exp Allergy 2004 34 1448-1457. [Pg.139]

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial-Italy (MAST-I)... [Pg.58]

A recent study compared 144 patients treated within 6 hours of symptom onset with I AT using urokinase versus 147 patients treated with aspirin who were matched for age and stroke severity according to National Institutes of Health Stroke Scale (NIHSS) (median 14). The study demonstrated superiority of LAT to aspirin in patients achieving an mRS score of 0-2 (56% vs. 42%, p = 0.037) and in patients achieving an mRS score of 0-1 at 2 years (40% vs. 24%, p = 0.008) with no difference in mortality (23% vs. 24%). °... [Pg.65]

In the Multicenter Acute Stroke Trial Italy (MAST-I) study, 622 patients were randomized in a 2 X 2 factorial design to receive either a 1-hour infusion of 1.5 lU streptokinase or 300 mg aspirin or both, or neither. Streptokinase (alone or with aspirin) was associated with a greater number of fatahties at 10 days (OR 2.7,95% Cl 1.7. 3). In MAST-I, neither aspirin monotherapy nor combination therapy reduced the primary outcome of combined 6-month fatahty and severe disability. [Pg.144]

When the CAST collaborative group performed a meta-analysis of 1ST, CAST, and MAST-I, the trend seen in CAST and 1ST toward a beneficial effect of aspirin on the rate of death or dependency reached the threshold for statistical significance. Early aspirin therapy (160-300 mg/day) conferred an absolute reduction in the rate of recurrent ischemic stroke by 0.7% (7 per 1000 patients treated) (p < 0.001) and reduced the rate of death or dependency by 1.3% (13 per 1000 patients treated) (2p = 0.007). Aspirin caused about 2 hemorrhagic strokes among every 1000 patients treated, but prevented about 11 other strokes or deaths in hospital. [Pg.144]

Combination GP Ilb/IIIa and rt-PA Therapy for Acute Stroke The combination of antiplatelet and thrombolytic drugs has proven efficacy in the setting of myocardial ischemia where an additive effect is seen. In acute stroke thrombolysis with a very narrow time window and less than 50% optimal reperfusion rates,adjunctive therapy with antiplatelets may be a promising approach. However, MAST-I concluded that the group of patients receiving streptokinase plus aspirin had a marked increase in 10-day mortality. [Pg.147]

Aspirin (100-300 mg/day) may be given within 48 hours after ischemic stroke (Level of Evidence I). [Pg.156]

Dedicated plants predominate in the bulk chemicals industry. They suit the manufacture of well-defined products using a determined technology. Any change of the product or the production process usually produces problems, which illustrates the inflexibility of a dedicated plant. A batch plant may also be operated as a dedicated plant to produce a single chemical. Some fermentation plants (with reactors of up to 200 m volume) are examples of dedicated batch plants for the production of a family of similar products. So-called bulk fine chemicals, i.e. compounds that are produced in larger quantities, are also manufactured in dedicated plants, e.g. vitamin C and aspirin (see Fig. 7.1-1). The va.st majority of batch plants, however, produce several chemicals. [Pg.437]


See other pages where I Aspirin is mentioned: [Pg.187]    [Pg.96]    [Pg.144]    [Pg.185]    [Pg.71]    [Pg.219]    [Pg.303]    [Pg.471]    [Pg.78]    [Pg.79]    [Pg.81]    [Pg.83]    [Pg.187]    [Pg.96]    [Pg.144]    [Pg.185]    [Pg.71]    [Pg.219]    [Pg.303]    [Pg.471]    [Pg.78]    [Pg.79]    [Pg.81]    [Pg.83]    [Pg.144]    [Pg.329]    [Pg.52]    [Pg.85]    [Pg.108]    [Pg.81]    [Pg.265]    [Pg.234]    [Pg.169]    [Pg.145]    [Pg.201]    [Pg.46]    [Pg.144]   
See also in sourсe #XX -- [ Pg.861 ]




SEARCH



© 2024 chempedia.info